FDA Expands Approval for Antidepressant Nasal Spray

The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression.Parkside Psychiatric Hospital has a Spravato outpatient clinic on-site and has seen more than 20 patients each week with positive results.It was initially approved in 2019 to treat resistant depression.FDA ApprovalSpravato is a nasal... Read More.

FDA to Cut Nicotine From Cigarettes, in Plan First Floated Under Trump

WASHINGTON — The Food and Drug Administration is moving to cut out addictive nicotine from cigarettes, according to a long-awaited proposed regulation released Wednesday.The rule aims to force the nearly 12% of Americans still using combustible tobacco products to switch to less dangerous alternatives, like vaping electronic cigarettes or using nicotine lozenges, or quit... Read More.